Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate.

Knudsen, L S; Ostergaard, M; Baslund, B; Narvestad, E; Petersen, J; Nielsen, H J; Ejbjerg, B J; Szkudlarek, M; Johansen, J S

Knudsen, L S; Ostergaard, M; Baslund, B; Narvestad, E; Petersen, J; Nielsen, H J; Ejbjerg, B J; Szkudlarek, M; Johansen, J S.

Scand J Rheumatol ; 35(6): 489-91, 2006.

Article in En | MEDLINE | ID: mdl-17343261

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/blood; Glycoproteins/blood; Interleukin-6/blood; Methotrexate/therapeutic use; Vascular Endothelial Growth Factor A/blood; Adipokines; Adult; Aged; Arthritis, Rheumatoid/diagnostic imaging; Arthritis, Rheumatoid/drug therapy; Chitinase-3-Like Protein 1; Female; Humans; Infliximab; Lectins; Male; Middle Aged; Radiography

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Glycoproteins / Methotrexate / Interleukin-6 / Antirheumatic Agents / Vascular Endothelial Growth Factor A / Antibodies, Monoclonal Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Scand J Rheumatol Year: 2006 Document type: Article Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Search on Google

Add to My VHL

XML

PubMed Links